Michelson Medical Research Foundation, Inc. — 13F Holdings & Portfolio

CIK 1965304 · latest 13F-HR filed 2026-08-14

Michelson Medical Research Foundation, Inc. manages $108.2M in 13F-reported U.S. long-equity assets across 21 reported positions as of its 2026-06-30 13F-HR filing. Its largest disclosed positions are IVE (10.89%), VEA (10.41%), BLDR (8.02%). Quarter over quarter (versus its 2026-03-31 filing) the fund opened 2 new positions and exited 2; 15 existing positions rose in reported value and 3 fell.

AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.

Loading holdings…
AUM
$108.2M

Long-equity book

Holdings
21

Distinct positions

Period
2026-06-30

Filed 2026-08-14

Q/Q Activity
+2 / −2 / ↑15 / ↓3

vs 2026-03-31

Portfolio charts

Latest quarter's book, what changed, and how the portfolio has evolved across filings.

Portfolio map

Q2 26

Box size = position value; colour = change in share count vs the prior quarter (green added, red trimmed, blue new). Rows split across managers or share classes are combined. Click a box for the stock.

Sector mix

% of 13F value

Sectors from each company's SIC code; funds and ETFs grouped separately.

Biggest buys and sells

Q1 26 → Q2 26

Estimated from the change in shares held × the quarter-end price, so price moves alone don't count as buying. New and exited positions are included.

13F assets and positions

4 quarters

Total reported 13F value (bars) and number of positions (line) each quarter. Value changes include market moves.

Top positions over time

reported value

The eight largest current positions, valued at each quarter end.

Concentration

top 10 = 72.1%

Cumulative share of the portfolio held in the largest N positions.

Firm Profile & Key People
Name Title / Status Ownership Type

Quarter-over-quarter changes

Changes in reported position value vs the prior 13F, so price moves count too, not just shares bought or sold.

Top Adds (vs prior quarter)

Show all 15 →

Top Trims

Show all 3 →

Michelson Medical Research Foundation, Inc. Holdings (2026-06-30)

Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).

# Issuer Symbol CUSIP Value Weight Shares Type
1 ISHARES TR IVE 464287408 $11.8M 10.89% 51,905 SH
2 VANGUARD TAX-MANAGED FDS VEA 921943858 $11.3M 10.41% 158,160 SH
3 BUILDERS FIRSTSOURCE INC BLDR 12008R107 $8.7M 8.02% 97,000 SH
4 CME GROUP INC CME 12572Q105 $8.6M 7.96% 39,000 SH
5 VANGUARD INTL EQUITY INDEX F VWO 922042858 $7.6M 7.04% 127,630 SH
6 ISHARES TR IWC 464288869 $7.1M 6.54% 35,385 SH
7 CANNAE HLDGS INC CNNE 13765N107 $6.9M 6.39% 480,600 SH
8 ISHARES TR IBB 464287556 $6.7M 6.17% 35,095 SH
9 SPDR SERIES TRUST KRE 78464A698 $4.8M 4.39% 63,510 SH
10 SAFEHOLD INC SAFE 78646V107 $4.7M 4.32% 297,477 SH
11 MANCHESTER UTD PLC NEW MANU G5784H106 $4.6M 4.24% 200,000 SH
12 ISHARES INC EWY 464286772 $4.1M 3.76% 20,155 SH
13 VANGUARD INDEX FDS VB 922908751 $3.3M 3.08% 11,010 SH
14 ISHARES INC EWW 464286822 $3.2M 2.91% 41,850 SH
15 ISHARES INC EWT 46434G772 $3.0M 2.75% 27,435 SH
16 ISHARES INC EWZ 464286400 $2.8M 2.59% 81,300 SH
17 ATLANTA BRAVES HLDGS INC BATRK 047726302 $2.3M 2.16% 45,130 SH
18 OAKTREE SPECIALTY LENDING OCSL 67401P405 $2.0M 1.88% 170,100 SH
19 ISHARES INC EWJ 46434G822 $1.9M 1.73% 20,100 SH
20 CRESCENT ENERGY COMPANY CRGY 44952J104 $1.5M 1.42% 156,166 SH
21 SPDR INDEX SHS FDS GXC 78463X400 $1.4M 1.34% 16,750 SH
Filing History
Period Filed AUM Holdings Accession
2026-06-30 2026-08-14 $108.2M 21 0001965304-26-000003
2026-03-31 2026-05-15 $98.5M 21 0001965304-26-000002
2025-12-31 2026-02-17 $99.8M 20 0001965304-26-000001
2025-09-30 2025-11-14 $115.0M 20 0001965304-25-000002
Filer Information
Address
11755 WILSHIRE BLVD.
SUITE 1400
LOS ANGELES, CA 90025
Phone
(310) 806-9700
Filing Manager
Michelson Medical Research Foundation, Inc.
Los Angeles, CA
Signatory
David Cohen
Chief Financial Officer